ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

Advisors suggest NCI establish sarcoma research consortium.

January 30, 2004

Court Upholds FDA Position On Definition Of A Drug.

February 23, 2001

NCI CTEP Approved Trials For the Month of February

February 22, 2013

Concepts For Computer Support Services Ok’d By NCAB Committee

September 25, 1992

Klausner: “The More We Know About The Causes, The Better We Are at Prevention”

June 27, 1997

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006